viernes, 31 de diciembre de 2010

Antibioticos para neumonia intrahospitalaria y asociada a ventilador

From: Murillo Santucci Cesar de Assunção <murilloa@uol.com.br>
Sent: Fri, December 31, 2010 9:10:52 AM
Subject: ATB Agents for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

 

 


Este fascículo está muito bom!!!
Enjoy it!!

 


ATB Agents for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
Workshop on Clinical Trials of Antibacterial Agents for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

 
Clinical Infections Diseases Volume 51 Supplement 1 August 1, 2010


Supplement Articles
Executive Summary

          o John G. Bartlett,
          o Philip S. Barie,
          o Michael S. Niederman,
          o and Richard G. Wunderink
      Workshop on Clinical Trials of Antibacterial Agents for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S1-S3 doi:10.1086/653066
         
          o Brad Spellberg, George Talbot, and for the Infectious Diseases Society of America, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine
      Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S150-S170 doi:10.1086/653065   

          o Steven L. Barriere
      Challenges in the Design and Conduct of Clinical Trials for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: An Industry Perspective
      Clin Infect Dis. (2010) 51(Supplement 1): S4-S9 doi:10.1086/653033
        
          o David N. Gilbert
      Scenario 1: A Patient with Hospital-Acquired Bacterial Pneumonia—Introduction to Clinical Trial Design Issues
      Clin Infect Dis. (2010) 51(Supplement 1): S10-S11 doi:10.1086/653034
        
     
          o Michael S. Niederman
      Hospital-Acquired Pneumonia, Health Care-Associated Pneumonia, Ventilator-Associated Pneumonia, and Ventilator-Associated Tracheobronchitis: Definitions and Challenges in Trial Design
      Clin Infect Dis. (2010) 51(Supplement 1): S12-S17 doi:10.1086/653035
         
  
          o John H. Powers
      Recommendations for Improving the Design, Conduct, and Analysis of Clinical Trials in Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S18-S28 doi:10.1086/653036
         

          o Marin H. Kollef
      Review of Recent Clinical Trials of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Perspective from Academia
      Clin Infect Dis. (2010) 51(Supplement 1): S29-S35 doi:10.1086/653037
         
  
          o Alfred Sorbello,
          o Scott Komo,
          o Thamban Valappil,
          o and Sumati Nambiar
      Registration Trials of Antibacterial Drugs for the Treatment of Nosocomial Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S36-S41 doi:10.1086/653038
      
  
          o Thomas M. File, Jr.
      Recommendations for Treatment of Hospital-Acquired and Ventilator-Associated Pneumonia: Review of Recent International Guidelines
      Clin Infect Dis. (2010) 51(Supplement 1): S42-S47 doi:10.1086/653048
        
          o Antoni Torres,
          o Miquel Ferrer,
          o and Joan Ramón Badia
      Treatment Guidelines and Outcomes of Hospital-Acquired and Ventilator-Associated Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S48-S53 doi:10.1086/653049
        
          o Jean Chastre and
          o Charles-Edouard Luyt
      Other Therapeutic Modalities and Practices: Implications for Clinical Trials of Hospital-Acquired or Ventilator-Associated Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S54-S58 doi:10.1086/653050
         
          o Donald E. Craven and
          o Karin I. Hjalmarson
      Ventilator-Associated Tracheobronchitis and Pneumonia: Thinking Outside the Box
      Clin Infect Dis. (2010) 51(Supplement 1): S59-S66 doi:10.1086/653051
         
          o Lena M. Napolitano
      Use of Severity Scoring and Stratification Factors in Clinical Trials of Hospital-Acquired and Ventilator-Associated Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S67-S80 doi:10.1086/653052
        
          o Ronald N. Jones
      Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S81-S87 doi:10.1086/653053
         
          o Jean Chastre,
          o Jean-Louis Trouillet,
          o Alain Combes,
          o and Charles-Edouard Luyt
      Diagnostic Techniques and Procedures for Establishing the Microbial Etiology of Ventilator-Associated Pneumonia for Clinical Trials: The Pros for Quantitative Cultures
      Clin Infect Dis. (2010) 51(Supplement 1): S88-S92 doi:10.1086/653054
       
          o Michael S. Niederman
      The Argument against Using Quantitative Cultures in Clinical Trials and for the Management of Ventilator-Associated Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S93-S99 doi:10.1086/653055
        
          o David N. Gilbert
      Scenario 2: A Patient with Ventilator-Associated Bacterial Pneumonia—Introduction to Clinical Trial Design Issues
      Clin Infect Dis. (2010) 51(Supplement 1): S100-S102 doi:10.1086/653056
         
          o Paul G. Ambrose,
          o Sujata M. Bhavnani,
          o Evelyn J. Ellis Grosse,
          o and George L. Drusano
      Pharmacokinetic-Pharmacodynamic Considerations in the Design of Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Studies: Look before You Leap!
      Clin Infect Dis. (2010) 51(Supplement 1): S103-S110 doi:10.1086/653057
        
          o Cynthia F. Kleppinger and
          o Leslie K. Ball
      Building Quality in Clinical Trials With Use of a Quality Systems Approach
      Clin Infect Dis. (2010) 51(Supplement 1): S111-S116 doi:10.1086/653058
        
          o Katherine A. Laessig
      End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration Perspective
      Clin Infect Dis. (2010) 51(Supplement 1): S117-S119 doi:10.1086/653059
         
          o John G. Muscedere,
          o Andrew Day,
          o and Daren K. Heyland1
      Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator-Associated Pneumonia and Hospital-Acquired Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S120-S125 doi:10.1086/653060
         
          o Richard G. Wunderink
      Surrogate Markers and Microbiologic End Points
      Clin Infect Dis. (2010) 51(Supplement 1): S126-S130 doi:10.1086/653061
      
          o Marya D. Zilberberg and
          o Andrew F. Shorr
      Ventilator-Associated Pneumonia: The Clinical Pulmonary Infection Score as a Surrogate for Diagnostics and Outcome
      Clin Infect Dis. (2010) 51(Supplement 1): S131-S135 doi:10.1086/653062
         
          o John S. Bradley
      Considerations Unique to Pediatrics for Clinical Trial Design in Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S136-S143 doi:10.1086/653063
         
          o George H. Talbot
      Considerations in Undertaking a Clinical Development Program for Hospital-Acquired Bacterial Pneumonia and/or Ventilator-Associated Bacterial Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S144-S149 doi:10.1086/653064
      
          o John G. Bartlett,
          o Richard G. Wunderink,
          o Michael S. Niederman,
          o and Philip S. Barie
      Workshop on Issues in the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
      Clin Infect Dis. (2010) 51(Supplement 1): S171 doi:10.1086/653067
         
Links

 

http://www.mediafire.com/?pqn290ke5g3aicb

or
http://ifile.it/r5dni1h/WSClinicalTrialsAntibacterialAgentsHospitalAcquiredPneumoniaVAP_MA1972.rar
 


Murillo Santucci Cesar de Assunção
Unidade de Terapia Intensiva adulto
Disciplina de Anestesiologia, Dor e Terapia Intensiva
Escola Paulista de Medicina
Rua Napoleão de Barros,715
Vila Clementino - São Paulo - CEP: 04024-002
Tel/Fax: +55-11-55757768
Tel/Fax: +55-11- 55764069
m.assuncao@unifesp.br
murilloassuncao@gmail.com

No hay comentarios:

Publicar un comentario en la entrada